These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35846794)

  • 61. Comprehensive analysis of the prognostic value and immune infiltration of
    Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
    Front Oncol; 2022; 12():936952. PubMed ID: 36147913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma.
    Shao C; Cheng C; Shao Q; Chen B
    Int J Gen Med; 2021; 14():3497-3509. PubMed ID: 34295178
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selenoprotein GPX3 is a novel prognostic indicator for stomach adenocarcinoma and brain low-grade gliomas: Evidence from an integrative pan-cancer analysis.
    Wang Y; Fu G; Chen X; Xia Z; Qi M; Du X; Liu K; Liu Q; Sun N; Shi C; Qu K; Zhang R
    Heliyon; 2024 Jun; 10(11):e32271. PubMed ID: 38873671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
    Zhu H; Wang G; Zhu H; Xu A
    J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
    [No Abstract]   [Full Text] [Related]  

  • 65.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma.
    Xu Z; Xiang L; Peng L; Gu H; Wang Y
    Comput Math Methods Med; 2022; 2022():3445230. PubMed ID: 36148016
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Gong W; Dai W; Wei H; Chen Y; Zheng Z
    Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma.
    Lyu Z; Li Y; Zhu D; Wu S; Hu F; Zhang Y; Li Y; Hou T
    Front Cell Dev Biol; 2022; 10():859999. PubMed ID: 35359436
    [No Abstract]   [Full Text] [Related]  

  • 69. Expression and prognosis analysis of
    Li H; Li Q; Jing H; Zhao J; Zhang H; Ma X; Wei L; Dai R; Sun W; Suo Z
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):707-716. PubMed ID: 34719199
    [No Abstract]   [Full Text] [Related]  

  • 70. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FUT11 expression in gastric cancer: its prognostic significance and role in immune regulation.
    Huang Y; Yang X; Wei M; Yang X; Yuan Z; Huang J; Wei J; Tian L
    Discov Oncol; 2024 Jun; 15(1):250. PubMed ID: 38941002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer.
    Zhao Q; Zhong J; Lu P; Feng X; Han Y; Ling C; Guo W; Zhou W; Yu F
    PPAR Res; 2021; 2021():6629842. PubMed ID: 33613670
    [TBL] [Abstract][Full Text] [Related]  

  • 74. GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma.
    Ni L; Chen S; Liu J; Li H; Zhao H; Zheng C; Zhang Y; Huang H; Huang J; Wang B; Lin C
    Mediators Inflamm; 2023; 2023():7123568. PubMed ID: 37124060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma.
    Zhang CH; Xu ZQ; Peng LL; Wang JJ; Gu HT
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6725-6741. PubMed ID: 36196721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
    Wang Z; Wang K; Yu X; Chen M; Du Y
    J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
    [No Abstract]   [Full Text] [Related]  

  • 77.
    Li X; Fan Y; Zhang Y; Wang Y; Zhao M; Tang M; Li H; Mi J; Geng Z; Wang Z; Su F
    Front Genet; 2022; 13():876588. PubMed ID: 35571047
    [No Abstract]   [Full Text] [Related]  

  • 78. DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer.
    Deng Z; Xiao M; Du D; Luo N; Liu D; Liu T; Lian D; Peng J
    Onco Targets Ther; 2021; 14():2003-2017. PubMed ID: 33776450
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019.
    Luo L; Zheng Y; Li M; Lin X; Li X; Li X; Cui L; Luo H
    Front Genet; 2020; 11():575770. PubMed ID: 33193689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.